ISR News and Press, IsoRay Inc. From 11/10/20

IsoRay (ISR): FQ1 GAAP EPS of -$0.01 beats by $0.01.Revenue of $2.38M (+2.6% Y/Y) misses by $0.07M.Shares -4.28%.Press Release For further details see: IsoRay EPS beats by $0.01, misses on revenue

Revenue Increased 3% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 104% Year-Over-Year RICHLAND, Wash., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expandin...

RICHLAND, Wash., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference call to discuss its financial results for the first quarter fiscal 2021 ended Septem...

CACI International (CACI) is providing electro-optical/infrared (EO/IR) sensors, which deliver data that can be analyzed faster and enable real-time aerial heat-mapping technology, to support firefighting operations. John Mengucci, CACI President and Chief Executive Officer, said, “As ...

Thinly traded nano cap Isoray (ISR) slumps 26% premarket on robust volume in reaction to its public offering of ~18.3M common shares and five-year warrants to purchase ~9.1M shares at a combined price of $0.52 per share and accompanying warrant.Gross proceeds should be ~$9.5M.Yester...

RICHLAND, Wash., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, announced the pricing of its public offering of 18,269,230 shares of its common st...

Isoray (ISR) intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. Actual size and terms yet to be finalised.Press Release For further details see: Isoray proposes underwritten public offering

RICHLAND, Wash., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it in...

AngioDynamics (ANGO) has launched Auryon Atherectomy System, a newly-developed innovative laser technology for the treatment of Peripheral Artery Disease ((PAD)), including Critical Limb Ischemia ((CLI)) and In-Stent Restenosis (ISR) with minimal impact on vessel walls. Jim Clemmer, AngioDyna...

IsoRay, Inc. (ISR) Q4 2020 Results Conference Call September 17, 2020 4:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants Ed Woo - Ascendiant Capital Swayampakula Ramakanth - H.C. Wainwright Presentation...